We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.73%
AUM
$7.55B
AUM Growth
+$1.25B
Cap. Flow
+$1.17B
Cap. Flow %
15.56%
Top 10 Hldgs %
9.43%
Holding
2,269
New
635
Increased
628
Reduced
448
Closed
556
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17%
2 Financials 13.53%
3 Healthcare 13.33%
4 Technology 13.18%
5 Industrials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
NGNE icon
1626
Neurogene
NGNE
$479M
$118K ﹤0.01%
2,218
+858
+63% +$224K
2018 Q1
1 quarter
RRD
1627
DELISTED
RR Donnelley & Sons
RRD
$117K ﹤0.01%
20,277
-103,094
-84% -$761K
2018 Q1
1 quarter
DX icon
1628
Dynex Capital
DX
$2.53B
$116K ﹤0.01%
5,900
+767
+15% +$15K
2017 Q3
3 quarters
FSP icon
1629
Franklin Street Properties
FSP
$38.4M
$116K ﹤0.01%
+13,523
New +$107K
2018 Q2
0 quarters
OVID icon
1630
Ovid Therapeutics
OVID
$417M
$115K ﹤0.01%
+14,700
New +$126K
2018 Q2
0 quarters
BRG
1631
DELISTED
Bluerock Residential Growth REIT
BRG
$115K ﹤0.01%
+12,897
New +$115K
2018 Q2
0 quarters
ELGX
1632
DELISTED
Endologix
ELGX
$115K ﹤0.01%
2,039
-2,829
-58% -$143K
2018 Q1
1 quarter
KEYW
1633
DELISTED
KEYW Holding
KEYW
$114K ﹤0.01%
+13,000
New +$109K
2018 Q2
0 quarters
RIOT icon
1634
Riot Platforms
RIOT
$6.39B
$112K ﹤0.01%
17,603
-4,897
-22% -$35.8K
2018 Q1
1 quarter
ORC icon
1635
Orchid Island Capital
ORC
$843M
$111K ﹤0.01%
+2,945
New +$109K
2018 Q2
0 quarters
TXMD icon
1636
TherapeuticsMD
TXMD
$22.5M
$109K ﹤0.01%
348
-986
-74% -$301K
2018 Q1
1 quarter
RMTI icon
1637
Rockwell Medical
RMTI
$26.4M
$108K ﹤0.01%
+199
New +$119K
2018 Q2
0 quarters
GALT icon
1638
Galectin Therapeutics
GALT
$294M
$105K ﹤0.01%
+16,578
New +$80.7K
2018 Q2
0 quarters
TNAV
1639
DELISTED
Telenav
TNAV
$105K ﹤0.01%
18,753
+3,453
+23% +$18.8K
2017 Q3
3 quarters
XIN
1640
DELISTED
Xinyuan Real Estate
XIN
$103K ﹤0.01%
+2,319
New +$121K
2018 Q2
0 quarters
NEOS
1641
DELISTED
Neos Therapeutics
NEOS
$103K ﹤0.01%
16,500
+4,300
+35% +$32.1K
2017 Q4
2 quarters
RBBN icon
1642
Ribbon Communications
RBBN
$256M
$102K ﹤0.01%
14,314
-3,060
-18% -$17.9K
2017 Q4
2 quarters
GAU icon
1643
Galiano Gold
GAU
$558M
$100K ﹤0.01%
+93,699
New +$106K
2018 Q2
0 quarters
AFH
1644
DELISTED
Atlas Financial Holdings
AFH
$98K ﹤0.01%
+11,232
New +$119K
2018 Q2
0 quarters
SEAC
1645
DELISTED
SeaChange International
SEAC
$95K ﹤0.01%
1,390
-2,115
-60% -$129K
2017 Q4
2 quarters
ZIXI
1646
DELISTED
Zix Corp
ZIXI
$95K ﹤0.01%
+17,694
New +$91K
2018 Q2
0 quarters
BW icon
1647
Babcock & Wilcox
BW
$636M
$94K ﹤0.01%
+3,969
New +$105K
2018 Q2
0 quarters
CLNE icon
1648
Clean Energy Fuels
CLNE
$357M
$94K ﹤0.01%
25,492
-792
-3% -$1.87K
2017 Q4
2 quarters
GOGL icon
1649
DELISTED
Golden Ocean Group
GOGL
$93K ﹤0.01%
+10,685
New +$89.7K
2018 Q2
0 quarters
TALO.WS icon
1650
DELISTED
Talos Energy Warrants
TALO.WS
$91K ﹤0.01%
+19,146
New +$96.5K
2018 Q2
0 quarters

Similar funds

Squarepoint's Q2 2018 Portfolio in Review

As of Q2 2018, Squarepoint held 2,269 positions worth $7.55B, up 20% from $6.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Squarepoint deployed $1.17B of net new capital in Q2 2018, opening 635 new positions and adding to 628 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI India ETF, an estimated $47.3M trimmed.

  • Squarepoint's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
  • Squarepoint added most to iShares MSCI Taiwan ETF in Q2 2018, an estimated $102M increase.
  • Squarepoint's biggest Q2 2018 reduction was iShares MSCI India ETF, cutting an estimated $47.3M.
  • Squarepoint fully exited iShares MSCI Brazil ETF in Q2 2018, selling an estimated $119M.
  • Squarepoint's ten largest holdings make up 9.4% of its $7.55B portfolio in Q2 2018.
  • Squarepoint opened 635 new positions and closed 556 in Q2 2018.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.55B.

Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.